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A unique amyloid fibril protein has been isolated from the liver of new inbred 
strains of mouse termed "SAM"  (senescence-accelerated mouse) (1).  SAM  is a 
murine model of accelerated senescence developed in our laboratory and consists 
of P-l, P-2, P-3, and P-4 series and as a control R series (R-l, R-2, and R-3) (2). 
Spontaneous, age-associated, systemic amyloidosis is one of the most character- 
istic  findings in  these  mice (2,  3).  The  unique  amyloid fibril  protein  termed 
"ASSAM" has a mol wt of 5,200 daltons and amino acid composition differs from 
amyloid  protein  of any  other  spontaneous  amyioidosis  in  mice  and  murine 
secondary amyloidosis (1).  Specific antiserum was raised against ASSAM and the 
uniqueness of ASSAM was also confirmed by immunochemical and immunohisto- 
chemical techniques (3,  4).  No relationship was observed between ASSAM and 
murine protein AA and mouse immunoglobulin component. 
Circulating  precursors  that  reacted  with  antisera  against  amyloid  protein 
isolated from amyloid tissues were noted in several types of amyloidosis. Preal- 
bumin in familial amyloid polyneuropathy (5-7),  senile cardiac amyloidosis (8, 
9),  and senile plaque  (10),  and  SAA (serum AA) in human and  experimental 
secondary amyloidosis (11-13) are examples. Among them, SAA has been most 
extensively  investigated  and  it  became  evident  that  this acute-phase  reactant 
serum protein was transported in association with plasma high density lipopro- 
reins (HDL) in humans (14,  15), rabbits (16), and mice (17). 
Using antisera  raised against ASSAM, we observed that normal mouse serum 
has a  substance  that  reacts  with  this antiserum and  we  termed this substance 
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"SASsAM"  (Serum  ASsAM-related antigenic  substance).  This substance circulates 
in the  form of high  density lipoprotein and its apoprotein,  which  has the  same 
molecular weight as ASSAM, was identified. 
Materials and  Methods 
Isolation of ASs.~w  Murine senile amyloid protein "ASSAM" was extracted from the livers 
of P-1 series mice of SAM and purified by gel chromatography through Sephadex G-100 
in 5 M guanidine-HCl,  1 N acetic acid, as described previously by Matsumura et al. (1). 
Antisera.  Anti-GDAM antiserum was obtained in rabbits by immunizing with guani- 
dine-denaturated-unfractionated amy!oid fibril protein (GDAM) and absorbed thoroughly 
with mouse liver acetone powder, as described by Higuchi et al. (4). 
Anti-ASsAM antiserum  was  prepared  by  immunizing  with  purified  ASSAM and  this 
antiserum  was  used  in  double  immunodiffusion tests and  for detecting  protein  bands 
transferred to nitrocellulose paper (immuno blotting test). 
Antiserum to murine protein AA was also raised (4). 
Source of Sera.  Old (14 too) and newborn P-1 series mice of SAM, R-1 series mouse (5 
mo)  and  mice  of several  strains  (A/J,  CBA/St,  C3H/HeN,  C57BL/6J,  SJL/J,  B10A, 
S lc'ICR, and DDD) were anesthetized with ether and bled by cardiac puncture. These 
sera, and human and rat sera, were tested against anti-ASsA~  and anti-AA antiserum by 
the double immunodiffusion test in agar gel.  For isolation of each lipoprotein fraction, 
sera were obtained from the old  P-1  series of SAM,  DDD mice, and CBA/St mice in 
which the serum concentration of SAA had been elevated by the subcutaneous injection 
of 300 #g lipopolysaccharide (LPS) in saline (18). All these sera were usually used without 
freezing. DDD mice serum was used for Sephadex G-200 gel chromatography. 
Fractionation  of Lipoprotein.  Lipoprotein  fractions  of different  density  classes  were 
prepared by preparative ultracentrifugation (19) in a Hitachi 65p ultracentrifuge. 6 ml of 
mouse sera in  each  tube  were overlayed with  phosphate-buffered saline  (pH  7.2)  and 
centrifuged in a  RP-40 rotor for 18 h at 40,000 rpm and  10°C. The top quarter of the 
tube was removed by careful aspiration into a syringe with a flat-tipped needle (very low 
density lipoprotein: VLDL, d <  1.006). The remaining lipoproteins of serum were isolated 
by preparative ultracentrifugation (40,000 rpm, 10°C, 44 h) in a RP-40 rotor into three 
fractions,  low density  lipoprotein  (LDL),  1.006  <  d  <  1.163,  and  two classes  of high 
density lipoprotein:HDL~,  1.063  <  d <  1.125,  HDLs,  1.125  <  d  <  1.210.  Increase of 
density to that of the next lipoprotein fraction was carried out by appropriate additions 
of a  high  density solution  (d  =  1.346)  (19).  The infranatant of the finally centrifuged 
solution at density  1.210  g/cm  3 was separated into three fractions, serially from top to 
bottom. Each of four lipoprotein fractions and three infranatant fractions were dialyzed 
in cellulose dialyzer tubing (8,000-9,000 daitons cutoff) against 0.15 M NaCI containing 
0.05% Na2-EDTA adjusted to pH 7.0 with 0.1  N NaOH at 4°C. 
Delipidation  of HDL,~ and HDLs.  HDL2  and  HDLs  fractions  were  dialyzed  against 
distilled water and iyophilized. Apo HDL~ and apo HDLs were obtained by delipidation 
with  3:2 (vol/vol) ethanol/diethyl  ether at -10°C as described by Scanu and Edelstein 
(2O). 
Column Chromatography.  Whole mouse serum was fractionated on a  1.5  cm x  90 cm 
column of Sephadex G-200 eluted with 0.1  M Tris-HCl in 1 N NaCI, pH 8.0 at 4°C. The 
delipidated preparation (Apo HDL2 and apo HDLs) was dissolved in 8 M urea in 0.01  M 
Tris-HCl, 1 mM EDTA pH 8.6 and fractionated on 1.5 cm × 90 cm column of Sephadex 
G-200 equilibrated  with  the same urea buffer at 20°C.  Pooled effluent fractions were 
dialyzed exhaustively in cellulose dialyzer tubing (3,500  daltons cutoff) against distilled 
water and lyophilized. The urea recrystailized from ethanol or ultra pure urea (Schwarz/ 
Mann  Inc., Orangeburg, NY) was used for gel chromatography and polyacrylamide gel 
electrophoresis. 
Quantitation of SASsa~ and SAA.  Quantitation of SASsAu and SAA was performed with 
single radial immunodiffusion test in  1% agar gel containing antibodies.  1 mg each of 
purified ASSAM and protein AA was dissolved by heating for 2 min at  100°C in  I  ml of 1602  SENILE  AMYLOID-RELATED  ANTIGENIC SUBSTANCE IN SERUM 
0.2% SDS, 0.01 M phosphate buffer, pH 7.4, then diluted with an appropriate  volume of 
0.28% Tween 20, 0.01 M phosphate  buffer, pH 7.4, and these protein solutions were 
used as standards. 
Double Immunodiffusion and Immunoelectrophoresis.  Double  immunodiffusion  and im- 
munoelectrophoresis were performed in 1% agarose gel in 0.07% barbital buffer, pH 8.6. 
The plates were developed at room temperature and examined at 48 h. The plates of 
immunoelectrophoresis  were washed in phosphate-buffered  saline, pH 7.2, desalted  in 
distilled water,  immersed in 5% acetic acid in 75% ethanol,  dried at 80°C, and stained 
for lipid with 1:4 (vol/vol) Oil Red O/Fat Red 7B solution in 60% ethanol and for protein 
with 1% Amide Black 10B solution. 
Gel Electrophoretic Analysis.  The method of Swank and Munkres (21) was used for 8 M 
urea-sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis  (PAGE). Purified 
ASSAM and apo  HDL2 first subjected  to 8 M urea-SDS-PAGE were electrophoretically 
transferred from the gel to nitro-cellulose paper (92). Protein bands reacting with antisera 
(anti-GDAM antiserum  and anti-ASsAM antiserum)  were detected by using  l~SI-labeled 
protein A (New England Nuclear, Boston, MA) and subsequent autoradiography  at -80 °C 
(22). Analytical PAGE for apolipoprotein  was performed by the method of Davis (23) on 
the gel with 7.5% acrylamide and 8 M urea. 
Other Analytical Procedures.  Total protein was determined by the method of Lowry et 
al. Total cholesterol concentration was estimated by the 0-phthalaldehyde method (Cho- 
lesterol B-test Wako, Wako Pure Chemical Industries Ltd., Osaka, Japan). 
Results 
Detection of ASs~-related Antigenic  Substance in Serum  (SASsAM).  Old P-1  series 
mice serum  (14  mo)  gave  a  single precipitation  line,  when  tested by  double 
immunodiffusion against  anti-ASsAM antiserum  and  this  line  fused  with  the 
precipitation  line  detected against  purified ASSAM. Absorption  of anti-ASsAM 
antiserum with purified ASSAM (0.05  mg per  1 ml of antiserum) eliminated the 
line between the mouse serum and antiserum. All sera obtained from mice of 
several strains such as P-1  series, R-1  series, A/J, CBA/St, CBA/HeN, C57BL/ 
6J, SJL/J, B 10A, S 1  c: 1  CR and DDD, showed a single precipitation line with anti- 
ASSAM antiserum in agar gel. Those precipitation lines fused with the line formed 
by purified ASSAM and P-1  mice serum. 
However, rat and human sera  showed no precipitation line (Fig.  1).  These 
mouse sera were also tested against anti-AA antisera by the double immunodif- 
fusion test (Table  I).  None of the sera obtained from any strain reacted with 
anti-AA antiserum, however, the sera from a C57BL/6J mouse and CBA/St mice 
with an  ulcer  at  the  neck  and amyloid deposition in  the  liver and  spleen  at 
autopsy, and with high levels of SAA by injection of LPS, respectively, did react 
with the anti-AA antiserum, 
In the immunoelectrophoresis, a  single precipitation line was  formed at the 
albumin/prealbumin region between mouse serum and anti-ASsAM antiserum. 
This precipitation line was positively stained with both Amide Black 10B and Oil 
Red O/Fat Red 7B solution (Fig. 2).  In Fig. 2B, a and/~ lipoproteins of mouse 
serum were stained with Oil Red O/Fat Red 7B solution and the precipitation 
line of serum ASsAM-related substance corresponded to the line of a  lipoprotein 
or high density lipoprotein. 
Sephadex  G-200  Chromatography.  Sephadex G-200  chromatography of DDD 
mouse whole serum is illustrated in Fig. 3.  In addition to the concentration of 
ASsAM-related substance, the amount of IgM, IgG and albumin of each fraction HIGUCHI ET AL.  1603 
FIGURE  |.  Detection of serum ASsAM-related antigenic substance (SASsAM) by double im- 
munodiffusion. Anti-ASs^~ antiserum in central wells was tested against purified ASSAM  (/4, D, 
and P), old P-1 mouse (14 mo) (A), new born P-I mice (B), R-1 mouse (5 too) (C), DDD mice 
(E), Slc:ICR (F), CBA/St (G), C3H/HeN (I), C57BL/6J (J), A/J (K), SJL/J (L), B10A (M), rat 
(N), and human (O) serum. 
were  measured  by a  single  radial  immunodiffusion  test  for  molecular  weight 
standards.  ASSAM immunoreactivity appeared as a single peak in a  position just 
before the peak of IgG and the molecular weight was estimated to be ~200,000 
daltons (Fig. 3). 
Determination of the SASsAM and SAA Concentration in Lipoprotein Fractions.  The 
concentrations of total protein, total cholesterol, serum ASsAM-related  substance 
(SASsAM), and SAA are given in Table II.  In sera obtained from old P-1  series 
mice  and  DDD  mice,  the  largest  amount  of SASsAM was  found  in  the  HDL~ 
fraction,  63.3% and 54.0% of total SASsAM were obtained in HDLz fractions of 
P-1  mice and DDD mice, respectively. In HDL3 fractions of P-1  mice and DDD 
mice,  21.6%  and  37.5% were detected, respectively. Thus, almost 90% of total 
SASsAM was found in high density lipoprotein fractions.  The remaining SASsAM 
was  found  in  the  LDL  fraction  (DDD  mice)  and  the  second  layer  below  the 
HDL3 fractions at a density 1.21  g/cm 3 (15.1% and 6.8% in P-1  and DDD mice, 
respectively). Although  SAA was not detected in any fraction of P-1  and  DDD 
mice, the HDL~ fraction of CBA/St mice serum in which SAA level was increased 
by injection of LPS contained 68.7% of SAA. 
Chromatography of Apolipoproteins.  Sephadex  G-200  chromatography  in  8  M 
urea,  0.01  M  Tris,  0.01  M  EDTA pH 8.6 of the delipidated  HDL2 and  HDL3 
fractions (apo HDL2 and apo HDL3) obtained from  DDD mice is illustrated  in 
Fig.  4.  Apo  HDL2 iipoproteins  were separated  by Sephadex  G-200  into  three 
distinctly defined  ultraviolet absorbing  peaks.  Slight  immunoreactivity  to anti- 
ASSAM antiserum  was  found  at  the  first  peak  (void  volumes),  but  almost  all 
SASsAM was found at  the third  peak.  A  trace amount  of SAA was observed at 
the third  peak (Fig.  4B).  It was more difficult to dissolve apo HDL3 than  apo 
HDL2 in  8  M  urea  buffer and  there  was  some difference between chromato- 
graphic  patterns  of apo  HDL2 and  apo  HDL~.  Apo  HDL3 was separated  into 
four  peaks  and  the  first  peak  (void  volume)  was  greater  than  apo  HDL2.  A 
considerable amount  of SASsAM was found  here.  However, the  major peak  of 
SASsAM was observed in the third peak, its position being the same as the third T
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FIGURE 2.  Immunoelectrophoresis in 1.0% agarose gel at pH 8.6 of DDD mice serum. After 
electrophoresis (anode is to the right) the upper troughs were  filled with anti-mouse whole 
serum and the lower troughs were filled with anti-ASsAM in each slide A and B. After washing 
and drying, slide A was stained with Amide Black 10B and slide B was stained with Oil Red O 
and Fat Red 7B. SASsAM precipitate (arrow) was stained with Oil Red O  and Fat Red 7B and 
migrated to the position of a-lipoproteins of serum (double arrows). 
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FIGURE  3.  Sephadex G-200 chromatography of DDD mice serum (2.0 m]) in  1.0 M  NaCI, 
0.1  M  Tris-HC],  pH  8.6.  Fraction  volume,  2.6  ml,  column  size,  1.5  cm  x  90  cm,  arrows 
indicate elution position of molecular weight standards (IgM; mouse IgM,  IgG; mouse IgG, 
and Alb; mouse albumin). (  ) Absorbance at 280 nm, (0"-----0) concentration of SASs^M 
represented as ASSAM  equivalent (~g/ml). T
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FIGURE 4.  Sephadex  G-200 gel  chromatography in  8  M  urea,  0.01  M  Tris-HC1,  0.01  M 
EDTA, pH 8.6 of delipidated HDL fractions from DDD mice serum. (A) Apo HDL= and (B) 
apo HDLs.  Fraction volume, 3.0 ml, column size, 1.5 cm x  90 cm. (  ) Absorbance at 280 
nm, (H)  concentration of SASs^m and ((3  (3) concentration of SAA as protein AA 
equivalent (pg/ml). 
peak of apo HDL2. Immunoreactivity to anti-AA antiserum was also detected in 
the third peak, but the amount was considerably less than  that of SASsAM. The 
pooled fractions of each peak were dialyzed against distilled water in cellulose 
tubing, lyophilized, and analyzed in the following electrophoretic procedures, as 
described in Materials and Methods. 
Electrophoretic Analysis.  8  M  urea  SDS  polyacrylamide  gel  electrophoretic 
patterns of apo HDL2, peaks separated by Sephadex G-200 from apo HDL~ are 
shown in  Fig.  5.  Apo HDL2 contained  -~ 12 protein bands.  In these bands, the 
two largest had mol wt of 25,000 and 5,200 daltons, respectively. The first peak 
of apo  HDL2 contained  several  high  molecular  weight  bands  and  the  second 
peak contained a bond with a mol wt calculated to be 25,000 daltons. The third 
peak of apo HDL~, which  had  immunoreactivity  to anti-ASsAm contained  moi 
wt 5,200 band, as a main protein band, and a few minor protein bands. Purified 
ASSAM had a mol wt of 5,200 daitons and was the same as the main protein band 1608  SENILE AMYLOID-RELATED ANTIGENIC SUBSTANCE IN SERUM 
FIGURE 5.  8 M urea SDS polyacrylamide (12.5%) gel chromatography of delipidated mouse 
HDL. (A) apo HDL2, (B) the second peak, and (C) the third  peak materials isolated by gel 
chromatography of apo HDL~, (D) purified ASSAM. Molecular weight markers, phosphorylase 
b  (94,000),  albumin  (67,000), ovalbumin  (43,000),  carbonic  anhydrase  (30,000),  trypsin 
inhibitor  (20,100), myoglobin (16,949), myoglobin I and II (14,400), myoglobin I (8,159), 
myoglobin II (6,214), myoglobin III (2,512). 
FIGURE 6.  Antibody labeling of apo HDL2 and tissue amyloid fibril proteins  separated  by 
SDS-PAGE. (A) Gel used for protein  blot transfer to nitrocellulose stained with Coomassie 
Brilliant Blue. (a) apo HDL~, and (b) purified  ASSAM. (B) Autoradiograms  of protein  after 
labeling with anti-purified ASSAM and subsequent reaction with ~25I-labeled  protein A. (a) apo 
HDL2 and (b) purified ASSAM. Molecular weight markers were same as Fig. 5. 
of the  third  peak of apo HDL2.  The third  peak of apo HDLs also had a  main 
band of mol wt 5,200  daltons but there were also some minor bands of low tool 
wt proteins.  The antigenic  relationship of the tissue and serum constituent  was 
demonstrated  after transfer to  nitrocellulose  paper by labeling with  antibodies 
specific for tissue amyloid protein (Fig. 6).  Purified amyloid protein (ASSAM) had 
only one band that reacted with the antibody.  Apo HDL2 contained two bands, 
the major one corresponding to a  band of the third peak of apo HDL2 and the 
minor one  -~42,000  daltons.  No other protein of apo HDL2 reacted with anti- 
ASSAM antiserum.  In each of these experiments, the same result was obtained in HIGUCHI ET AL.  1609 
FIGURE 7.  Anionic (pH 9.4) 8 M urea polyacrylamide  gel (7.5%) electrophoresis  of (A) apo 
HDL2, (B) the third peak materials  isolated  by gel chromatography of apo HDL~ and (C) 
purified ASSAM. 
both cases in which anti-GDAM antiserum and anti-ASsAM antiserum were used 
as antiserum.  Fig.  7  shows the anionic polyacrylamide gel electrophoretic pat- 
terns.  Apo HDL~ contained seven major apoprotein bands.  The third peak of 
apo  HDL2  contained  several  proteins that  migrated  faster  and  the  first  three 
bands corresponded to purified ASSAM separated into the three or four bands. 
The third peak of apo HDL3 separated into many minor bands but the position 
of the major bands were the same as in the case of the purified ASSAM. 
Discussion 
Purified  amyloid  fibril  proteins  have  been  obtained  from  several  types  of 
amyloidosis (24). Specific antisera were raised against these amyloid proteins and 
serum amyloid-related  substances  that  reacted  with the  antisera  were  investi- 
gated. Generally these substances were considered to be precursors of amyloid 
proteins. To clarify the pathogenesis of amyioidosis or mechanisms of deposition 
of amyloid protein, the nature of these precursors has to be determined. 
In humans, immunoglobulin light chain (25,  26) for the primary amyloidosis 
and SAA (11-13) for the secondary amyioidosis were confirmed to be precursors 
circulating in blood. In the case of senile amyloidosis (senile cardiac amyloidosis 
and senile plaque), prealbumin is considered to be amyloidIrelated protein (8- 
10).  Although senile amyloidosis has  long been  detected  in  mice (27,  28,  29) 
little is known of the pathogenesis of amyloidosis and the biochemical nature of 
amyloid protein and its precursor protein. 
We  isolated a  unique senile amyloid fibril  protein from the liver of SAM, a 
new murine model of accelerated senescence. We found that mouse serum has a 
ASsAM-related antigenic substance, regardless of the strain, and we termed this 
substance  "SASsAM."  SASsAM seems to be a  physiological substance  in contrast 
with acute phase reactant protein SAA (30) as demonstrated in Fig.  1 and Table 
2. The data obtained in immunoelectrophoresis (Fig. 2), and gel chromatography 
(Fig. 3) of mouse serum and also affinity chromatography of mouse serum using 
CNBr-activated  Sepharose  4B  coupled with  anti-ASsAM  IgG  (data  not  shown) 1610  SENILE  AMYLOID-RELATED  ANTIGENIC SUBSTANCE  IN SERUM 
revealed that SASsAM may be transported as a  form of high density lipoprotein 
(HDL) in serum. 
The determination of SASsAM concentration in lipoprotein fractions separated 
by ultracentrifugation  provided convincing evidence that the bulk of SASsAM is 
associated with  the HDL fractions of mouse serum, and the largest amount of 
SASsAM  is  related  to  the  HDL2  subfraction  of  HDL.  SAA  is  a  well-known 
precursor of protein  AA and  is associated with  HDL. The  relative amount of 
SAA was the largest in the HDL3 fraction in humans (15), rabbits (16), and mice 
(17).  In  the present study, the relative amount of SAA was also highest in  the 
HDL~ fraction (1.125 <  d <  1.210), 68.7% of SAA was found in HDLs of CBA 
mice serum with elevated concentrations of SAA after injection of LPS. On the 
other hand, the largest amount of SASsAM was found in the HDL2 fraction (1.063 
<  d <  1.125) in  DDD and SAM serum ('~60%  to the total), and SAA was not 
detected in either HDL2 and HDL~ fractions in DDD and SAM. 
Partial purification of the protein part of SASsAM achieved by delipidation of 
HDL and subsequent gel chromatography in 8 M urea containing buffer revealed 
that  the protein  part of SASsAM was a  low molecular weight apolipoprotein  of 
HDL. This apoprotein  was designated as apo SASsAM. Apo SASsAM was eluted 
as the third  peak in Sephadex G-200 gel chromatography  (Fig.  4) and was the 
same as in the case of SAA reported by Benditt et al. (17). In this study, however, 
AA immunoactivity  was scarcely detectable in  this position of both HDL2 and 
HDL~ fractions. 
8  M  urea SDS-PAGE of apo HDL2 demonstrated  two major components of 
apo HDL2. One is an apoprotein with a mol wt of 25,000 daltons and the other 
is  a  protein  with  a  mol  wt  of  ,~5,200  dahons.  The  25,000-dalton  protein 
corresponds  to  apo  A-I  protein  of human  and  rat  (31) and  the  5,200-dalton 
protein corresponds to apo C proteins (32). SDS-polyacrylamide gel electropho- 
resis of the  third  peak  of HDL2 separated  by Sephadex  G-200  and  antibody 
labeling of apo HDL2 transferred to nitrocellulose paper demonstrated that apo 
SASsAM is a protein with a mol wt of 5,200 and this molecular weight is the same 
as ASSAM isolated from the liver. Here, another minor band was observed in the 
position of 42,000 daltons and such is now under investigation. SAA is considered 
to be degraded by an enzyme of monocyte origin (33-36) or circulates in serum 
(37,  38)  and  deposits  in  tissues.  In  the  case  of SASsAM, the  finding  that  the 
molecular weight of apo SASsAM was the same as ASSAM supports the possibility 
that  apo  SASsAM deposits in  tissues,  without  degradation.  Further  studies are 
underway to determine whether SASsAM is the precursor of ASSAM. In anionic 8 
M urea polyacrylamide electrophoresis, apolipoprotein of the third peak of HDL2 
and purified ASSAM separated into three or four bands. This finding seems to be 
the result of polymorphism in  ASSAM, as is the case with protein  AA and SAA 
(39-41). 
It is noteworthy that both apo SASsAM and apo SAA are low molecular weight 
apolipoproteins of HDL, although there are differences in molecular weight, the 
distribution in HDL fractions (32) and concentration in normal serum. This class 
of peptides may be prone to deposition in tissues in the form of amyloid fibrils. HIGUCHI ET AL.  161 1 
This idea is supported by the finding that protein AA coexists with ASSAM in 
SAM in the presence of inflammatory lesions, as reported in a  previous paper 
(4). 
Apolipoprotein has been little investigated in mice, despite the usefulness of 
this species as an experimental tool. Hence, the function of apo SASsAM corre- 
sponding to apo C  proteins, is poorly understood. The C apoproteins play an 
important role in the metabolism of lipoprotein (42-45). Whether the physiolog- 
ical function of apo SASsAM is related to this mode or to a  heretofore unrecog- 
nized role, is the subject of ongoing study. Elucidation of this function will aid 
in  understanding the pathogenesis of amyloidosis. SASsAM was present in  the 
serum of all the strains we studied. Therefore, it is tempting to postulate that 
ASSAM is a common fibril protein that originates from a common serum precursor 
in the case of murine senile amyloidosis. 
Summary 
Sera  obtained  from senescence-accelerated mouse (SAM) and  normal  mice 
contained a substance that reacted with antiserum raised against ASSAM, a novel 
senile amyloid fibril protein isolated from the liver of SAM. 
This physiological substance, termed "SASsAM" (serum ASsAM-related antigenic 
substance), migrated to the albumin/prealbumin region in immunoelectropho- 
resis and the precipitation  line formed with anti-ASsaM  antiserum was stained 
positively with both Amide Black  10  B and Oil  Red O/Fat  Red 7B solutions, 
thereby suggesting that SASsAM is an a  lipoprotein. Using Sephadex G-200 gel 
chromatography, SASsAM was eluted as a high mol wt form of -~200,000 daltons. 
Fractionation of lipoprotein from normal mouse serum by preparative ultra- 
centrifugation disclosed that SASsAM was found mainly in high density lipopro- 
tein, HDL (the density is between 1.063  and  1.21  g/cm3). The largest amount 
of SASsAM was found in the HDL2 fraction (the density is between  1.063  and 
1.125) and in this fraction SAA was not detected. Furthermore, ASSAM immu- 
noreactivity appeared in the low mol wt proteins (below 10,000 daltons) of apo 
HDL separated in the buffer containing 8 M urea through Sephadex G-200. 
In 8 M urea sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis 
(PAGE),  the  major  components of apolipoproteins  in  this  position,  possibly 
corresponding to apo C proteins, have the same molecular weight, 5,200 daltons, 
as ASSAM and this component was labeled by anti-ASsAM antiserum after transfer 
to nitrocellulose paper. 
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